PRESS RELEASE published on 09/18/2024 at 22:42, 1 year 8 months ago Rapport Financier Semestriel 2024
BRIEF published on 09/18/2024 at 22:20, 1 year 8 months ago NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results Revenue Increase Clinical Milestones Nanobiotix Financials NBTXR3 Progress Cash And Runway
BRIEF published on 09/18/2024 at 22:20, 1 year 8 months ago NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers du premier semestre 2024 Augmentation Des Revenus Résultats Financiers De Nanobiotix Progression De NBTXR3 Étapes Cliniques Marquantes De L'argent Et De La Piste
PRESS RELEASE published on 09/18/2024 at 22:15, 1 year 8 months ago NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results Nanobiotix updates on operational progress and reports Half Year 2024 financial results, showcasing clinical milestones and licensing agreements with Janssen. Cash reserves extended until Q4 2025 Financial Results Clinical Milestones NANOBIOTIX Half Year 2024 Janssen Agreement
PRESS RELEASE published on 09/18/2024 at 22:15, 1 year 8 months ago NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2024 Nanobiotix publie ses résultats financiers et présente les avancées de NBTXR3, une approche innovante en oncologie basée sur les nanoparticules. Nouvelles collaborations et perspectives de développement clinique Résultats Financiers Oncologie NANOBIOTIX NBTXR3 Nanoparticules
BRIEF published on 09/04/2024 at 22:20, 1 year 9 months ago NANOBIOTIX Enhances Supervisory Board with Two Key Additions Biotechnology Supervisory Board NANOBIOTIX Dr. Liu Anat Naschitz
BRIEF published on 09/04/2024 at 22:20, 1 year 9 months ago NANOBIOTIX renforce son Conseil de Surveillance avec deux ajouts clés Biotechnologie Conseil De Surveillance NANOBIOTIX Dr Liu Anat Nachitz
PRESS RELEASE published on 09/04/2024 at 22:15, 1 year 9 months ago NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth Nanobiotix announces key additions to Supervisory Board - Dr. Margaret A. Liu & Ms. Anat Naschitz. Expertise to drive growth in nanophysics-based therapies for cancer & major diseases Supervisory Board NANOBIOTIX Dr. Margaret A. Liu Ms. Anat Naschitz Nanophysics-based Therapies
BRIEF published on 09/03/2024 at 22:20, 1 year 9 months ago Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference Biotechnology Webcast Fireside Chat NANOBIOTIX Investment Conference
BRIEF published on 09/03/2024 at 22:20, 1 year 9 months ago Nanobiotix présentera à la 26e conférence annuelle mondiale sur l'investissement de HC Wainwright Biotechnologie Webcast Discussion Au Coin Du Feu NANOBIOTIX Conférence Sur L'investissement
Published on 06/06/2026 at 04:45, 1 day ago Battery X Metals Announces Closing of First Tranche of Private Placement to Advance Corporate Growth
Published on 06/06/2026 at 00:00, 1 day 4 hours ago Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
Published on 06/05/2026 at 17:00, 1 day 11 hours ago Silver Spruce Resources Inc. Provides an Update on the Jackie Project Acquisition
Published on 06/05/2026 at 15:00, 1 day 13 hours ago Norsemont Drills 20 Meters of 1.20 G/T Gold Equivalent at Bottom of Hole
Published on 06/05/2026 at 13:30, 1 day 15 hours ago CANEX Announces Gold Basin Resources Shareholders Approve Merger Arrangement With CANEX With 75.82% Support
Published on 06/06/2026 at 08:29, 20 hours 26 minutes ago Starting today, Trade Republic gives European retail investors direct access to IPOs
Published on 06/06/2026 at 00:20, 1 day 4 hours ago Guild Wars 3, Modern Evolution of the MMORPG, Announced at Summer Game Fest for PC and PlayStation 5
Published on 06/05/2026 at 23:05, 1 day 5 hours ago Quantinuum Announces Closing of Upsized Initial Public Offering
Published on 06/05/2026 at 19:06, 1 day 9 hours ago EQS-Adhoc: Brockhaus Technologies AG: The Company's Management Board intends to return approx. €180 million of the proceeds from the sale of the Bikeleasing Group to shareholders
Published on 06/05/2026 at 18:48, 1 day 10 hours ago Digital transformation journey takes centre stage at ANGOTIC 2026
Published on 06/05/2026 at 19:00, 1 day 9 hours ago ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 1 day 9 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 06/05/2026 at 19:00, 1 day 9 hours ago ALTAREIT - Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 1 day 9 hours ago ALTAREA : Descriptif du programme de rachat d'actions autorisé par l'assemblée générale mixte du 4 juin 2026 et mis en œuvre par la Gérance
Published on 06/05/2026 at 19:00, 1 day 9 hours ago ALTAREIT - DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES MAI 2026